comparemela.com

Latest Breaking News On - Analyst recommendations for zentalis pharmaceuticals - Page 1 : comparemela.com

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Rating of "Moderate Buy" from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target among […]

China
Diana-hausman
Stifel-nicolaus
Td-asset-management-inc
Zentalis-pharmaceuticals-company-profile
Analyst-recommendations-for-zentalis-pharmaceuticals
China-universal-asset-management-co
York-mellon-corp
Securities-exchange-commission
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals
Institutional-trading-of-zentalis-pharmaceuticals

HC Wainwright Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $40.00

HC Wainwright Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $40.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
Stifel-nicolaus
Melissab-epperly
Diana-hausman
Zentalis-pharmaceuticals-company-profile
Eventide-asset-management
Decheng-capital
Zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-stock-performance

Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Target Price at $38.57

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […]

China
Melissab-epperly
Securities-exchange-commission
Exchange-traded-concepts
Zentalis-pharmaceuticals-stock
China-universal-asset-management-co
Quest-partners
Nasdaq
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-inc
Analyst-recommendations-for-zentalis-pharmaceuticals

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $38.57 Consensus Price Target from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year […]

Melissab-epperly
Insider-transactions-at-zentalis-pharmaceuticals
Decheng-capital
Zentalis-pharmaceuticals-price-performance
Nasdaq
Institutional-investors-weigh-in-on-zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Vanguard-group-inc
Rafferty-asset-management
Zentalis-pharmaceuticals-inc
Hermes-inc

vimarsana © 2020. All Rights Reserved.